Acadian Asset Management’s MacroGenics MGNX Stock Holding History

Acadian Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.7M	Sell	2,542,643 -1,357	-0.1%	-$5.13K	0.01%	552
2026 Q1	$7.35M	Buy	2,544,000 +25,590	+1%	+$54.6K	0.01%	602
2025 Q4	$4.05M	Buy	2,518,410 +863	+0%	+$1.36K	0.01%	711
2025 Q3	$4.22M	Buy	2,517,547 +25,844	+1%	+$41.8K	0.01%	695
2025 Q2	$3.01M	Buy	2,491,703 +183,054	+8%	+$266K	0.01%	720
2025 Q1	$2.92M	Buy	2,308,649 +1,017,726	+79%	+$2.66M	0.01%	662
2024 Q4	$4.19M	Buy	1,290,923 +199,098	+18%	+$717K	0.01%	568
2024 Q3	$3.59M	Buy	1,091,825 +505,746	+86%	+$1.97M	0.01%	582
2024 Q2	$2.49M	Buy	586,079 +112,666	+24%	+$1.1M	0.01%	698
2024 Q1	$6.97M	Sell	473,413 -584,280	-55%	-$8.83M	0.02%	384
2023 Q4	$10.2M	Sell	1,057,693 -313,703	-23%	-$2.17M	0.04%	287
2023 Q3	$6.39M	Buy	1,371,396 +99,755	+8%	+$497K	0.03%	367
2023 Q2	$6.8M	Buy	1,271,641 +41,589	+3%	+$257K	0.03%	376
2023 Q1	$8.82M	Buy	1,230,052 +173,362	+16%	+$1.04M	0.04%	333
2022 Q4	$7.09M	Buy	1,056,690 +39,607	+4%	+$217K	0.03%	351
2022 Q3	$3.52M	Buy	1,017,083 +180,088	+22%	+$689K	0.02%	497
2022 Q2	$2.47M	Buy	836,995 +799,527	+2,134%	+$4.2M	0.01%	576
2022 Q1	$329K	Buy	+37,468	New	+$414K	﹤0.01%	1100
2021 Q3	–	Sell	-7,328	Closed	-$197K	–	1894
2021 Q2	$197K	Sell	7,328 -16,613	-69%	-$487K	﹤0.01%	1447
2021 Q1	$761K	Sell	23,941 -30,332	-56%	-$737K	﹤0.01%	1040
2020 Q4	$1.24M	Sell	54,273 -2,535	-4%	-$58.4K	﹤0.01%	914
2020 Q3	$1.43M	Sell	56,808 -112,948	-67%	-$3.08M	0.01%	769
2020 Q2	$4.74M	Buy	169,756 +9,491	+6%	+$165K	0.02%	501
2020 Q1	$933K	Buy	160,265 +133,855	+507%	+$1.22M	0.01%	811
2019 Q4	$287K	Buy	26,410 +10,879	+70%	+$108K	﹤0.01%	1205
2019 Q3	$198K	Sell	15,531 -76,150	-83%	-$1.1M	﹤0.01%	1323
2019 Q2	$1.56M	Sell	91,681 -45,366	-33%	-$779K	0.01%	693
2019 Q1	$2.46M	Buy	137,047 +131,967	+2,598%	+$2.28M	0.01%	638
2018 Q4	$65K	Buy	+5,080	New	+$85.2K	﹤0.01%	1369
2018 Q2	–	Sell	-16,893	Closed	-$424K	–	1788
2018 Q1	$424K	Buy	+16,893	New	+$410K	﹤0.01%	902

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Acadian Asset Management's MGNX Position: Q2 2026 in Review

Acadian Asset Management reduced its MacroGenics (MGNX) stake by 0.05% in Q2 2026, selling an estimated $5.13K and leaving 2,542,643 shares worth $11.7M. The position accounts for 0.01% of the portfolio, ranked #552.

Acadian Asset Management first reported a position in MGNX in Q1 2018 and has held it in 30 quarters since. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Acadian Asset Management held 2,542,643 shares of MacroGenics worth $11.7M as of Q2 2026.
Acadian Asset Management sold 1,357 MacroGenics shares in Q2 2026, an estimated $5.13K.
MacroGenics made up 0.01% of Acadian Asset Management's portfolio in Q2 2026, its #552 holding.
Acadian Asset Management first reported a position in MacroGenics in Q1 2018 and has held it in 30 quarters since.
112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.